Read next
Health
GLP-1 Drug Class Expands Beyond Diabetes into Cardiovascular Therapeutics
Clinical trial data confirms broader metabolic and systemic benefits, prompting health insurers to reassess coverage criteria.
Health
GLP-1 Supply Dynamics: Manufacturing Expansion and Commercial Insurance Shifts
Pharmaceutical manufacturers are investing billions in fill-finish capacity to meet rising demand for obesity and diabetes treatments.
Health
GLP-1 Supply Chain Expansion Drives Capital Investment in Peptide Synthesis
Pharmaceutical manufacturers scale specialized production facilities to meet unprecedented global demand for metabolic therapeutics.
Health
Long-Term Financial Hardship Shows Up in the Brain Decades Later
A long-running study links persistent money stress in early adulthood to measurable differences in thinking skills by the…
Health
Synthetic Biology Platforms Accelerate Timeline for Precision Oncology Therapies
High-throughput gene-editing frameworks are cutting target discovery phases in half for specialized cancer treatments.
Health
Algorithmic Biomarker Analysis Accelerates Early-Stage Diagnostics
Clinical trial results show machine learning models identifying circulating tumor DNA signatures up to 24 months before standard…